AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2021

Apr 8, 2021

34412_dirs_2021-04-08_af86041d-3ea0-4b21-995a-49069c2684ca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-04-06

Reporting Person: Schor Chen (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-06	Common Stock	S	8982	$13.039	Disposed	134746	Indirect
2021-04-06	Common Stock	S	7484	$13.039	Disposed	112261	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.61 to $13.38, inclusive.

F3: Represents 134,746 shares held directly by an irrevocable family trust having an independent trustee.

F4: Represents 112,261 shares held directly by an irrevocable family trust having an independent trustee.